The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment

Patients with chronic kidney diseases (CKD) are often treated with antiplatelets due to aberrant haemostasis. This study aimed to evaluate the bleeding risk with CKD patients undergoing pentoxifylline (PTX) treatment with/without aspirin. In this retrospective study, we used Taiwan’s National Health...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Jing-Hung, Chen, Yi-Chen, Ho, Chung-Han, Chen, Jui-Yi, Hsing, Chung-Hsi, Liang, Fu-Wen, Wu, Chia-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241975/
https://www.ncbi.nlm.nih.gov/pubmed/34188087
http://dx.doi.org/10.1038/s41598-021-92753-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241975/
https://www.ncbi.nlm.nih.gov/pubmed/34188087
http://dx.doi.org/10.1038/s41598-021-92753-4

Ejemplares similares